Marquette Asset Management LLC Takes Position in FONAR Co. (NASDAQ:FONR)

Marquette Asset Management LLC bought a new stake in shares of FONAR Co. (NASDAQ:FONR) in the 4th quarter, HoldingsChannel.com reports. The firm bought 8,587 shares of the medical equipment provider’s stock, valued at approximately $168,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Carmel Capital Partners LLC boosted its stake in shares of FONAR by 725.1% during the 4th quarter. Carmel Capital Partners LLC now owns 12,088 shares of the medical equipment provider’s stock valued at $236,000 after buying an additional 10,623 shares during the last quarter. Brandywine Global Investment Management LLC boosted its stake in shares of FONAR by 1.9% during the 3rd quarter. Brandywine Global Investment Management LLC now owns 87,606 shares of the medical equipment provider’s stock valued at $1,349,000 after buying an additional 1,600 shares during the last quarter. Acuitas Investments LLC bought a new position in FONAR during the fourth quarter worth $4,277,000. Finally, Money Concepts Capital Corp lifted its stake in FONAR by 1.3% during the third quarter. Money Concepts Capital Corp now owns 311,822 shares of the medical equipment provider’s stock worth $4,802,000 after purchasing an additional 3,870 shares during the last quarter. 50.64% of the stock is currently owned by hedge funds and other institutional investors.

FONAR Price Performance

FONR traded down $0.59 during trading hours on Friday, hitting $16.27. 8,979 shares of the stock were exchanged, compared to its average volume of 17,739. The stock has a 50-day simple moving average of $20.56 and a 200-day simple moving average of $18.93. FONAR Co. has a 12 month low of $12.13 and a 12 month high of $24.05. The stock has a market cap of $102.99 million, a price-to-earnings ratio of 8.84 and a beta of 1.12.

FONAR (NASDAQ:FONR) last announced its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported $0.54 earnings per share (EPS) for the quarter. FONAR had a return on equity of 8.47% and a net margin of 12.63%. The firm had revenue of $25.39 million for the quarter.

FONAR Company Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.